Unlocking the therapeutic potential of primary tumor-draining lymph nodes. 2019

Jossie Rotman, and Bas D Koster, and Ekaterina S Jordanova, and A Marijne Heeren, and Tanja D de Gruijl
Department of Obstetrics and Gynecology, Center for Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Lymph nodes draining the primary tumor are essential for the initiation of an effective anti-tumor T-cell immune response. However, cancer-derived immune suppressive factors render the tumor-draining lymph nodes (TDLN) immune compromised, enabling tumors to invade and metastasize. Unraveling the different mechanisms underlying this immune escape will inform therapeutic intervention strategies to halt tumor spread in early clinical stages. Here, we review our findings from translational studies in melanoma, breast, and cervical cancer and discuss clinical opportunities for local immune modulation of TDLN in each of these indications.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Jossie Rotman, and Bas D Koster, and Ekaterina S Jordanova, and A Marijne Heeren, and Tanja D de Gruijl
September 2013, JAMA surgery,
Jossie Rotman, and Bas D Koster, and Ekaterina S Jordanova, and A Marijne Heeren, and Tanja D de Gruijl
June 1992, Surgery, gynecology & obstetrics,
Jossie Rotman, and Bas D Koster, and Ekaterina S Jordanova, and A Marijne Heeren, and Tanja D de Gruijl
December 2022, Cancer immunology, immunotherapy : CII,
Jossie Rotman, and Bas D Koster, and Ekaterina S Jordanova, and A Marijne Heeren, and Tanja D de Gruijl
November 2020, Mathematical biosciences and engineering : MBE,
Jossie Rotman, and Bas D Koster, and Ekaterina S Jordanova, and A Marijne Heeren, and Tanja D de Gruijl
January 1975, Neoplasma,
Jossie Rotman, and Bas D Koster, and Ekaterina S Jordanova, and A Marijne Heeren, and Tanja D de Gruijl
May 2022, Biochimica et biophysica acta. Reviews on cancer,
Jossie Rotman, and Bas D Koster, and Ekaterina S Jordanova, and A Marijne Heeren, and Tanja D de Gruijl
January 2002, Annals of surgical oncology,
Jossie Rotman, and Bas D Koster, and Ekaterina S Jordanova, and A Marijne Heeren, and Tanja D de Gruijl
May 1999, Journal of immunology (Baltimore, Md. : 1950),
Jossie Rotman, and Bas D Koster, and Ekaterina S Jordanova, and A Marijne Heeren, and Tanja D de Gruijl
August 2021, International journal of molecular sciences,
Jossie Rotman, and Bas D Koster, and Ekaterina S Jordanova, and A Marijne Heeren, and Tanja D de Gruijl
August 2021, The American journal of pathology,
Copied contents to your clipboard!